Is it possible to simplify risk stratification scores for patients with ST-segment elevation myocardial infarction undergoing primary angioplasty?

Revista Portuguesa de Cardiologia

Volumn 32, Issue 12, 2013, Pages 967-973

  Timóteo, Ana Teresa ^a   Papoila, Ana Luísa ^a   Lopes, João Pedro ^a   Oliveira, José Alberto ^a   Ferreira, Maria Lurdes ^a   Ferreira, Rui Cruz ^a  

^a HOSPITAL DE SANTA MARTA   (Portugal)

Author keywords

Acute coronary syndromes; Prognosis; Risk scores

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE CORONARY SYNDROME; ADULT; ANGIOPLASTY; ARTICLE; CARDIOVASCULAR MORTALITY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; GRACE RISK SCORE; HEART ARREST; HEART FAILURE; HEART RATE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYSTOLIC BLOOD PRESSURE; COMPARATIVE STUDY; FEASIBILITY STUDY; MIDDLE AGED; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PROCEDURES;

ANGIOPLASTY; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84893671559     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.repc.2013.06.006     Document Type: Article

References (18)

1. Antoniucci D, Migliorini A, Parodi G, et al. Abciximab-supportedinfarct artery stent implantation for acute myocardialinfarction and long-term survival: a prospective, multi-center, randomized trial comparing infarct artery stentingplus abciximab with stenting alone. Circulation. 2004;109:1704-6.
2. Steg PG, Goldberg RJ, Gore JM, et al. Baseline character-istics, management practices, and in-hospital outcomes ofpatients hospitalized with acute coronary syndromes in theGlobal Registry of Acute Coronary Events (GRACE). Am J Cardiol. 2002;90:358-63.
3. Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk scorefor ST-elevation myocardial infarction: a convenient, bedside,clinical score for risk assessment at presentation. Circulation. 2000;102:2031-7.
4. Granger CB, Goldberg RJ, Dabbous O, et al. Predictors of hos-pital mortality in the Global Registry of Acute Coronary Events. Arch Intern Med. 2003;163:2345-53.
5. Andersen HR, Nielsen TT, Rasmussen K, et al. A com-parison of coronary angioplasty with fibrinolytic therapyin acute myocardial infarction. N Engl J Med. 2003;349:733-42.
6. Grines CL, Browne KF, Marco J, et al. A comparison of immedi-ate angioplasty with thrombolytic therapy for acute myocardialinfarction. The Primary Angioplasty in Myocardial InfarctionStudy Group. N Engl J Med. 1993;328:673-9.
7. Brodie BR, Hansen C, Stuckey TD, et al. Door-to-balloon timewith primary percutaneous coronary intervention for acutemyocardial infarction impacts late cardiac mortality in high-risk patients and patients presenting early after the onset ofsymptoms. J Am Coll Cardiol. 2006;47:289-95.
8. McNamara RL, Wang Y, Herrin J, et al. Effect of door-to-balloontime on mortality in patients with ST segment elevation myocar-dial infarction. J Am Coll Cardiol. 2006;47:2180-6.
9. Wivviott SD, Morrow DA, Frederick PD, et al. Performance of thethrombolysis in myocardial infarction risk index in the NationalRegistry of Myocardial Infarction-3 and -4: a simple index thatpredicts mortality in ST-segment elevation myocardial infarc-tion. J Am Coll Cardiol. 2004;44:783-9.
10. Addala S, Grines CL, Dixon SR, et al. Predicting mortality inpatients with ST-elevation myocardial infarction treated withprimary percutaneous coronary intervention (PAMI risk score). Am J Cardiol. 2004;93:629-32.
11. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing theareas under two or more correlated receiver operating char-acteristic curves: a nonparametric approach. Biometrics. 1988;44:837-45.
12. Pencina MJ, D'Agostino RB, Steyerberg EW. Extensions of netreclassification improvement calculations to measure useful-ness of new biomarkers. Stat Med. 2011;30:11-21.
13. Huang Y, Pepe MS, Feng Z. Evaluating the predictiveness of acontinuous marker. Biometrics. 2007;63:1181-8.
14. R Development Core Team. R: A language and environ-ment for statistical computing. Vienna, Austria: R foundationfor Statistical Computing; 2008. ISBN 3-900051-07-0, URLhttp://www. R-project. org
15. Goodman SG, Huang W, Yan AT, et al. The expanded GlobalRegistry of Acute Coronary Events: baseline characteristics,management practices, and hospital outcomes of patients withacute coronary syndromes. Am Heart J. 2009;158:193-201.
16. Fox KA, Carruthers K, Steg G, et al. Has the frequency ofbleeding changed over time for patients presenting with anacute coronary syndrome? The Global Registry of Acute Coro-nary Events. Eur Heart J. 2010;31:667-75.
17. Van de Werf F, Gore JM, Avezum A. Access to catheterisationfacilities in patients admitted with acute coronary syndrome:multinational registry study. BMJ. 2005;330:441-6.
18. Al Suwaidi J, Reddan DN, Williams K, et al. Prognostic implica-tions of abnormalities in renal function in patients with acutecoronary syndromes. Circulation. 2002;106:974-80.